Cargando…
Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymer...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244626/ https://www.ncbi.nlm.nih.gov/pubmed/34250188 http://dx.doi.org/10.1093/ofid/ofab243 |
_version_ | 1783715968221970432 |
---|---|
author | Pollock, Nira R Tran, Kristine Jacobs, Jesica R Cranston, Amber E Smith, Sita O’Kane, Claire Y Roady, Tyler J Moran, Anne Scarry, Alison Carroll, Melissa Volinsky, Leila Perez, Gloria Patel, Pinal Gabriel, Stacey Lennon, Niall J Madoff, Lawrence C Brown, Catherine Smole, Sandra C |
author_facet | Pollock, Nira R Tran, Kristine Jacobs, Jesica R Cranston, Amber E Smith, Sita O’Kane, Claire Y Roady, Tyler J Moran, Anne Scarry, Alison Carroll, Melissa Volinsky, Leila Perez, Gloria Patel, Pinal Gabriel, Stacey Lennon, Niall J Madoff, Lawrence C Brown, Catherine Smole, Sandra C |
author_sort | Pollock, Nira R |
collection | PubMed |
description | BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. METHODS: Consenting symptomatic and asymptomatic children (≤18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitoring. All tests had 2 independent reads to assess interoperator agreement. Patients with positive CareStart results were called and instructed to isolate pending RT-PCR results. The paired RT-PCR result was the reference for sensitivity and specificity calculations. RESULTS: Of 1603 participants, 1245 adults and 253 children had paired RT-PCR/CareStart results and complete symptom data. Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms. Sensitivity/specificity were 50.0% (95% CI, 41.0–59.0)/99.1% (95% CI, 98.3–99.6) in asymptomatic adults and 51.4% (95% CI, 34.4–68.1)/97.8% (95% CI, 94.5–99.4) in asymptomatic children. Sensitivity in all 234 RT-PCR-positive people was 96.3% with cycle threshold (Ct) ≤25, 79.6% with Ct ≤30, and 61.4% with Ct ≤35. All 21 false-positive CareStart tests had faint but normal bands. Interoperator agreement was 99.5%. Operational challenges included identification of faint test bands and inconsistent swab elution volumes. CONCLUSIONS: CareStart had high sensitivity in people with Ct ≤25 and moderate sensitivity in symptomatic people overall. Specificity was unexpectedly lower in symptomatic versus asymptomatic people. Excellent interoperator agreement was observed, but operational challenges indicate that operator training is warranted. |
format | Online Article Text |
id | pubmed-8244626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-82446262021-07-01 Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts Pollock, Nira R Tran, Kristine Jacobs, Jesica R Cranston, Amber E Smith, Sita O’Kane, Claire Y Roady, Tyler J Moran, Anne Scarry, Alison Carroll, Melissa Volinsky, Leila Perez, Gloria Patel, Pinal Gabriel, Stacey Lennon, Niall J Madoff, Lawrence C Brown, Catherine Smole, Sandra C Open Forum Infect Dis Major Articles BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. METHODS: Consenting symptomatic and asymptomatic children (≤18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitoring. All tests had 2 independent reads to assess interoperator agreement. Patients with positive CareStart results were called and instructed to isolate pending RT-PCR results. The paired RT-PCR result was the reference for sensitivity and specificity calculations. RESULTS: Of 1603 participants, 1245 adults and 253 children had paired RT-PCR/CareStart results and complete symptom data. Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms. Sensitivity/specificity were 50.0% (95% CI, 41.0–59.0)/99.1% (95% CI, 98.3–99.6) in asymptomatic adults and 51.4% (95% CI, 34.4–68.1)/97.8% (95% CI, 94.5–99.4) in asymptomatic children. Sensitivity in all 234 RT-PCR-positive people was 96.3% with cycle threshold (Ct) ≤25, 79.6% with Ct ≤30, and 61.4% with Ct ≤35. All 21 false-positive CareStart tests had faint but normal bands. Interoperator agreement was 99.5%. Operational challenges included identification of faint test bands and inconsistent swab elution volumes. CONCLUSIONS: CareStart had high sensitivity in people with Ct ≤25 and moderate sensitivity in symptomatic people overall. Specificity was unexpectedly lower in symptomatic versus asymptomatic people. Excellent interoperator agreement was observed, but operational challenges indicate that operator training is warranted. Oxford University Press 2021-05-26 /pmc/articles/PMC8244626/ /pubmed/34250188 http://dx.doi.org/10.1093/ofid/ofab243 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Articles Pollock, Nira R Tran, Kristine Jacobs, Jesica R Cranston, Amber E Smith, Sita O’Kane, Claire Y Roady, Tyler J Moran, Anne Scarry, Alison Carroll, Melissa Volinsky, Leila Perez, Gloria Patel, Pinal Gabriel, Stacey Lennon, Niall J Madoff, Lawrence C Brown, Catherine Smole, Sandra C Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title | Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title_full | Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title_fullStr | Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title_full_unstemmed | Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title_short | Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts |
title_sort | performance and operational evaluation of the access bio carestart rapid antigen test in a high-throughput drive-through community testing site in massachusetts |
topic | Major Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244626/ https://www.ncbi.nlm.nih.gov/pubmed/34250188 http://dx.doi.org/10.1093/ofid/ofab243 |
work_keys_str_mv | AT pollocknirar performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT trankristine performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT jacobsjesicar performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT cranstonambere performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT smithsita performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT okaneclairey performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT roadytylerj performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT morananne performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT scarryalison performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT carrollmelissa performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT volinskyleila performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT perezgloria performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT patelpinal performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT gabrielstacey performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT lennonniallj performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT madofflawrencec performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT browncatherine performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts AT smolesandrac performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts |